跳至主要内容
临床试验/NCT07044219
NCT07044219尚未招募不适用

The Effect of Chlorhexidine (0.5%) With Combination of Hyaluronic Acid on Postoperative Wound Healing After Lower Third Molar Removal: a Placebo Controlled Triple Blind Randomized Clinical Trial

University of Pecs1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
60
试验地点
1
主要终点
Wound healing

研究概览

简要总结

Our aim is to evaluate chlorhexidine-hyaluronic acid containing gel on postoperative wound healing regarding impacted lower third molar surgery.

详细描述

This is a triple-blind, placebo-controlled randomized clinical trial. Sixty patients will be randomly assigned to two treatment groups: Arm 1 receives Curasept DNA ADS periodontal gel during impacted third molar removal, while Arm 2 receives a placebo gel. Patient allocation uses an electronic randomization system with a 1:1 ratio. Baseline characteristics are recorded at the first clinical visit. The surgical procedure includes local anesthesia, mucoperiosteal flap elevation, bone removal with a surgical handpiece, and wound closure with non-resorbable sutures. Test gel or placebo is applied post-tooth removal, and patients are monitored postoperatively for pain, swelling, and wound healing, including follow-ups on the third, seventh and fourteenth days. Data analysis will use descriptive and statistical methods to evaluate efficacy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •patients having lower impacted third molar
  • •impaction pattern Pell-Gregory II/A, III/A, I/B, II/B, III/B that means partially impacted, partially erupted teeth, where primary wound closure is usually not possible;

排除标准

  • •systemic disease (diabetes, steroids, antiresorptive therapy);
  • •allergy on gel's compounds;
  • •pregnancy;
  • •active or subacute local infection at third molar tooth (pericoronitis);
  • •poor oral hygiene (based on the presence of active caries and/or plaque index of 2-3)

研究组 & 干预措施

Curasept DNA ADS periodontal gel

Experimental

干预措施: Third molar surgery (Procedure)

Placebo gel wound dressing

Placebo Comparator

干预措施: Third molar surgery (Procedure)

结局指标

主要结局

Wound healing

时间窗: From enrollment to the end of treatment at 2 weeks

Scoring wound healing according to Inflammatory Proliferative Remodelling (IPR) Wound Healing Scale: 0-16: the smaller number indicates the poorer outcome

次要结局

  • Mouth opening(From enrollment to the end of treatment at 2 weeks)
  • Subjective pain level(From enrollment to the end of treatment at 2 weeks)
  • Face swelling(From enrollment to the end of treatment at 2 weeks)
  • Taken analgesics (questionaire)(From enrollment to the end of treatment at 2 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Balazs Soos

Participating investigator

University of Pecs

研究点 (1)

Loading locations...

相似试验